VS-DDPM: Efficient Low-Cost Diffusion Model for Medical Modality Translation
Nikoo Moradi, Gijs Luijten, Behrus Hinrichs-Puladi, Jens Kleesiek, Victor Alves, Jan Egger, André Ferreira * · 2026
Read VS-DDPM: Efficient Low-Cost Diffusion Model for Medical Modality Translation by Nikoo Moradi, Gijs Luijten, Behrus Hinrichs-Puladi, Jens Kleesiek, Victor Alves, Jan Egger, André Ferreira * (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2604-22942.txt.
Introduction
Moradi and six colleagues present VS-DDPM, a variable-step diffusion model designed to keep generative quality while speeding inference severalfold for medical image synthesis. Tested on four tasks in the BraTS2025 and SynthRAD2025 challenges, it reaches state-of-the-art performance in missing MRI synthesis. For tumor removal it also performs strongly, while MRI-to-sCT and CBCT-to-sCT results stay competitive but below the best marks, possibly due to data processing. The framework offers a robust, tunable route to high-fidelity three-dimensional medical image synthesis.
Catalog record
| CREATOR | Nikoo Moradi, Gijs Luijten, Behrus Hinrichs-Puladi, Jens Kleesiek, Victor Alves, Jan Egger, André Ferreira * |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25039 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2604.22942
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
VS-DDPM: Efficient Low-Cost Diffusion Model for Medical Modality Translation Nikoo Moradi, Gijs Luijten, Behrus Hinrichs-Puladi, Jens Kleesiek, Victor Alves, Jan Egger, André Ferreira * Abstract Diffusion models produce high-quality synthetic data but suffer from slow inference. We propose 3D Variable-Step Denoising Diffusion Probabilistic Model (VS-DDPM) a framework engineered to maintain generative quality while accelerating inference by several factors. We tested our approach on four tasks—missing MRI, tumor removal, MRI-to-sCT, and CBCT-to-sCT—within the BraTS2025 and SynthRAD2025 challenges. Designed for high efficiency under hardware and time constrains imposed by both challenges. VS-DDPM achieved state-of-the-art (SOTA) performance in missing MRI synthesis, yielding Dice scores of 0.80, 0.83, and 0.88 for the enhancing tumor, tumor core, and whole tumor regions, respectively, alongside a structural similarity index (SSIM) of 0.95. For MRI tumor removal, the model attained a root mean squared error (RMSE) of 0.053, a peak signal-to-noise ratio (PSNR) of 26.77, and an SSIM of 0.918. While the framework demonstrated competitive performance in MRI-to-sCT and CBCT-to-sCT tasks, it did not reach SOTA benchmarks, potentially due to sensitivities in data pre and post-processing pipelines or specific loss function configurations. These results demonstrate that VS-DDPM provides a robust and tunable solution for high-fidelity 3D medical image synthesis. The code is available in GitHub . 1 Introduction Medical imaging plays a central role in the diagnosis and treatment of cancer patients, particularly in radiotherapy (RT), which is used in more than half of all cancer cases [ 16 ] . In RT, pre-treatment imaging is performed to develop a treatment plan, which is then delivered in daily fractions over several weeks. Traditionally, X-ray-based imaging, such as computed tomography (CT), has been the primary modality for patient positioning and monitoring before, during, or after treatment [ 4 ] . CT provides accurate anatomical geometry and essential electron density information for dose calculation. However, repeated CT scans expose patients to ionizing radiation, offer limited soft-tissue contrast, and are often not available directly in treatment rooms [ 6 ] . To overcome these limitations, other imaging methods are increasingly being used. Magnetic resonance imaging (MRI) offers superb soft-tissue contrast without ionizing radiation [ 15 ] . However, MRI scans lack the necessary attenuation data for dose calculations and optimization of the treatment plan [ 3 ] . Cone-beam computed tomography (CBCT) is widely used for in-room positioning and monitoring [ 2 ] , yet suffers from shading, streaking, and other artifacts that reduce image quality and limit its suitability for dose calculation [ 13 ] . Converting MRI or CBCT to synthetic CT (sCT) addresses these limitations by enabling accurate dose calculations from modalities with superior soft-tissue visualization or convenient in-room acquisition [ 16 ] . Efforts such as the SynthRAD2025 Grand Challenge [ 18 ] 1 1 1 https://synthrad2025.grand-challenge.org/synthrad2025/ , provide large datasets focusing on finding solutions for reducing the amount of radiation, by converting CBCT into CT or removing radiation entirely with MRI to CT conversion. Even when MRI only can be used for treatment planning, e.g. brain glioma, the long-time sessions and patient related constrains limits the quality of some modalities acquired, as 4 MRI modalities are necessary for a full informed decision. Therefore, generating the missing/low quality modality would increase the speed of diagnosis and treatment planing. The existence of morphological distortions, e.g. brain gliomas, also affects other treatments. This is particularly important for algorithms that have only been trained on healthy brains, such as brain extraction, tissue segmentation and brain anatomy parcellation algorithms. It is also important to monitor the expected progression of the brain tumor during treatment and to study biomarkers by comparing the healthy and unhealthy brain in other diseases such as Alzheimer’s. The BraTS2025 2 2 2 https://www.synapse.org/Synapse:syn64153130 provides a platform and several datasets aimed to help build solutions to solve these issues. With the tools provided by SynthRAD2025 and BraTS2025 datasets is possible to build solutions for: MRI-only RT: sCTs derived from MRI enable treatment planning and delivery without the need for a separate CT scan, thereby eliminating registration errors between MRI and CT, reducing radiation exposure, and simplifying clinical workflows [ 6 ] . Adaptive MRI- or CBCT-based RT: sCTs generated from MRI or CBCT allow accurate dose calculations on daily imaging, enabling treatment plan adaptation to anatomical changes throughout the course of therapy [ 16 ] . Faster MRI acquisition: Missing MRI modalities can be generated allowing algorithms that expect all modalities work correctly [ 7 ] . Brain correction: Removal of brain lesions that might affect treatment planing of other conditions [ 8 ] . To solve these challenges, we propose Variable-Step Denoising Diffusion Probabilistic Models (VS-DDPM), a high-quality and low resource generation pipeline that ensure realism and utility. Our approach is tested in 4 tasks: MRI to sCT, CBCT to sCT, missing modality generation and tumor removal. The code is available in GitHub 3 3 3 https://github.com/andre-fs-ferreira/SynthRAD_by_Faking_it . 2 Material and Methods 2.1 Dataset For the MRI to sCT and CBCT to sCT we use the datasets provided by the SynthRAD2025 Grand Challenge, a multi-center dataset designed to benchmark sCT generation methods [ 17 ] . The full dataset comprises 890 MRI-CT pairs, and 1,472 CBCT-CT pairs sourced from five European university medical centers. The data covers three anatomical regions: Head and Neck (HN), Thoracic (TH), and Abdominal (AB). The dataset is divided into training (65%), validation (10%), and testing (25%) subsets. For our research, we only used the publicly available training data, as the validation and testing ground truth images were withheld by the challenge organizers. For the MRI missing modality generation, the dataset is composed of 1251 training cases from the BraTS 2023 Glioma dataset [ 1 ] and 238 training cases from the BraTS 2023 MET dataset [ 10 ] . The modalities T1, T1-Gd, T2 and FLAIR and the respective segmentations are available for each case. For the tumor removal, the BraTS 2023 Glioma [ 1 ] dataset is also used, but only the T1 modality. No additional public datasets were used in this research. Data Preprocessing: The SynthRAD2025 datasets are provided with rigid registration to align the MRI/CBCT scans with the corresponding ground truth CT images, and defaced for anonymity. We performed deformable registration and implemented data augmentation to assess performance improvements. All modalities (CT, MRI, and CBCT) underwent spatial transformations, including 3 degree rotations, scaling, and grid distortion. MRI data was further augmented with intensity-specific perturbations: bias field effects, intensity shifts, and Gaussian smoothing/noise. For the BraTS 2023 dataset (already skull-stripped and rigidly registered), we employed the MRI augmentation used in the SynthRAD experiments, with the inclusion of shearing. To build the ground truth of the tumor removing task, random portions of the healthy region of the brain were selected using real tumor masks, creating a very large and diverse dataset. Data Splitting: We use the training dataset available and created a custom 90%/10% train-validation split using a uniformly random selection process. This ensured that our validation set included a representative number of cases from all anatomical regions and all participating medical centers. Data Normalization: For CT and CBCT normalization, we clip the intensities from a range of -1000 HU to 1600 HU and normalized linearly to a range of -1